94 related articles for article (PubMed ID: 27793664)
1. Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling.
Xu Z; Hong Z; Ma M; Liu X; Chen L; Zheng C; Xi X; Shao J
Biochem Biophys Res Commun; 2016 Nov; 480(4):586-593. PubMed ID: 27793664
[TBL] [Abstract][Full Text] [Related]
2. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
3. Rock2 stabilizes β-catenin to promote tumor invasion and metastasis in colorectal cancer.
Qiu Y; Yuan R; Zhang S; Chen L; Huang D; Hao H; Shao J
Biochem Biophys Res Commun; 2015 Nov; 467(4):629-37. PubMed ID: 26505794
[TBL] [Abstract][Full Text] [Related]
4. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
5. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
6. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
7. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.
Li M; Zhou W; Yuan R; Chen L; Liu T; Huang D; Hao L; Xie Y; Shao J
FEBS Lett; 2015 Apr; 589(9):1018-25. PubMed ID: 25771860
[TBL] [Abstract][Full Text] [Related]
8. Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation.
Gao W; Zhang S; Guorong L; Liu Q; Zhu A; Gui F; Zou Y; Wu Y; Luo Y; Hong Z
Cell Cycle; 2022 Feb; 21(4):340-351. PubMed ID: 34974812
[TBL] [Abstract][Full Text] [Related]
9. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
Wei W; Chua MS; Grepper S; So S
Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
[TBL] [Abstract][Full Text] [Related]
10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.
Wen X; Wang N; Zhang F; Dong C
Mol Med Rep; 2016 Mar; 13(3):2885-91. PubMed ID: 26847210
[TBL] [Abstract][Full Text] [Related]
12. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.
Boku S; Nakagawa S; Toda H; Kato A; Takamura N; Omiya Y; Inoue T; Koyama T
Brain Res; 2013 Jan; 1492():7-17. PubMed ID: 23211630
[TBL] [Abstract][Full Text] [Related]
13. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
14. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T
J Pathol; 2010 Dec; 222(4):410-20. PubMed ID: 20922712
[TBL] [Abstract][Full Text] [Related]
15. Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells.
Rena V; Angeletti S; Panzetta-Dutari G; Genti-Raimondi S
Placenta; 2009 Oct; 30(10):876-83. PubMed ID: 19679347
[TBL] [Abstract][Full Text] [Related]
16. Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.
Saegusa M; Hashimura M; Kuwata T
Lab Invest; 2012 Apr; 92(4):511-21. PubMed ID: 22231735
[TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J
Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445
[TBL] [Abstract][Full Text] [Related]
18. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin.
Choi H; Chun YS; Kim TY; Park JW
Cancer Res; 2010 Dec; 70(24):10101-11. PubMed ID: 21159632
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis.
Yan N; Zhang S; Yang Y; Cheng L; Li C; Dai L; Dai L; Zhang X; Fan P; Tian H; Wang R; Chen X; Su X; Li Y; Zhang J; Du T; Wei Y; Deng H
Cancer Sci; 2012 Sep; 103(9):1631-9. PubMed ID: 22642751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]